Search filters

List of works by Barbara Cybulska

2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders

scientific article published on 02 March 2020

Achieving target low‑density lipoprotein cholesterol levels in the Polish population

scientific article published on 01 January 2012

Chapter 9 Interaction of Polyene Macrolide Antibiotics with Lipid Model Membranes

Clinical management of heterozygous familial hypercholesterolemia in a Polish outpatient metabolic clinic: a retrospective observational study

scientific article published on 30 November 2017

Combination pharmacotherapy therapy in the management of atherogenic dyslipidemia

scientific article published in June 2005

Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).

scientific article

Current state-of-the-art knowledge on the role of omega-3 fatty acids in the prevention of cardiovascular disease

scientific article published on 07 September 2020

Facilitated diffusion of glucosamine-6-phosphate synthase inhibitors enhances their antifungal activity

scientific article

Homocysteine--is it still an important risk factor for cardiovascular disease?

scientific article published on January 2015

How do we know that statins are diabetogenic, and why? Is it an important issue in the clinical practice?

scientific article published on 01 August 2018

How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors

scientific article published on 28 December 2020

Interaction of amphotericin B and its low toxic derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester, with fungal, mammalian and bacterial cells measured by the energy transfer method

scientific article published on April 2004

Landmark studies in coronary heart disease epidemiology. The Framingham Heart Study after 70 years and the Seven Countries Study after 60 years

scientific article published on 01 January 2019

Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum

scientific article published on 01 January 2013

Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum

scientific article published on 18 February 2013

Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum

scientific article published on 4 February 2013

Management of familial hypercholesterolemia in children and adolescents. Position paper of the Polish Lipid Expert Forum

scientific article published on 18 January 2014

PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.

scientific article published on 19 December 2016

PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021

scientific article published on 9 November 2021

Polish Forum for Prevention Guidelines on Dyslipidaemia: update 2016

scientific article published on 01 January 2017

Polish Forum for Prevention Guidelines on cardiovascular diseases prevention in children and adolescents

scientific article published on 01 May 2010

Polish forum for prevention guidelines on dyslipidaemia

scientific article published on 01 November 2008

Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey

scientific article

Prevalence, diagnosis, and treatment of familial hypercholesterolaemia in outpatient practice in Poland

scientific article published on 5 February 2018

Prevention of ischaemic heart disease in the elderly. Reduction of coronary risk factors

scientific article published on 01 April 2003

Primary prevention of cardiovascular disease and other chronic noncommunicable diseases in the centre of attention of the United Nations: special importance of a prudent diet.

scientific article published on January 2013

Recommendation for the management of dyslipidemia in Poland - Third Declaration of Sopot. Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy

scientific article published on 01 January 2018

Severe hypercholesterolaemia--when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts' group statement

scientific article

Stanowisko dotyczące postępowania w rodzinnej hipercholesterolemii u dzieci i młodzieży. Stanowisko Forum Ekspertów Lipidowych

scientific article published in November 2013

Statins 25 years in preventive cardiology

scientific article published on 01 January 2012

Studies of the effects of antifungal cationic derivatives of amphotericin B on human erythrocytes

scientific article published in October 2004

The HDL paradox: what does it mean and how to manage low serum HDL cholesterol level?

scientific article published on 20 May 2014

The mechanism of overcoming multidrug resistance (MDR) of fungi by amphotericin B and its derivatives

scientific article published on 01 July 2007

Treatment of dyslipidemia

scientific article published in November 2002

Treatment of lipid disorders in metabolic syndrome and type 2 diabetes. The place for fibrates

scientific article published in June 2005

Visfatin--what is currently known about its role in physiology and pathology?

scientific article published on 01 January 2011

What do we know about lipoprotein(a)?

scientific article published on 07 January 2015

What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery?

scientific article published on 08 April 2020

What does obesity paradox mean in coronary heart disease?

scientific article published in January 2013

What is the future for niacin after the AIM-HIGH study?

scientific article published on 01 January 2012

[Actual problems of dyslipidaemia treatment in Poland - 2nd Declaration of Sopot. Experts' Group Consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy]

scientific article published on 01 January 2014

[Effectiveness of omega 3 fatty acids in ischaemic heart disease prevention]

scientific article published on 01 June 2005

[Evaluation of the coronary risk: is it enough to asses ApoB/ApoA1 ratio only or is plasma lipoprotein concentration still necessary?]

scientific article published on 01 February 2005

[Low-carbohydrate, high-fat diets: efficacy and safety]

scientific article published on 01 December 2004

[Management in familial hypercholesterolaemia in children and adolescents. Position of the Lipid Expert Forum]

scientific article published on 01 January 2013

[Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum]

scientific article published on 01 January 2013

[Metabolic syndrome as a coronary risk factor. Prevention and treatment]

scientific article published on 01 July 2003

[New European guidelines on cardiovascular disease prevention in relation to the situation in Poland]

scientific article published on 01 December 2004

[Safety of hypolipemic agents]

scientific article published on 01 October 2002

[Why fast food should be forbidden in Polish schools?]

scientific article published on 01 March 2009

Paulina is supported by:

About Paulina

Help